Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of irinotecan plus cyclosporine and phenobarbital in
treating patients who have solid tumors or lymphoma that is refractory to standard therapy.
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop
growing or die. Cyclosporine and phenobarbital may enhance the effectiveness of irinotecan.